Global Transglutaminase Market By Type (Tissue Transglutaminase (tTG), Microbial Transglutaminase (mTG); By Range (Below 50 u/g, 51 u/g – 100 u/g and above 100 u/g); By Application (Food Industry – Dairy: Yoghurt, Ice Cream, Cheese, Others, Bakery: Instant Noodles, Pasta, Others, Meat and Poultry, Fish and Seafood, Soyabean Products, Others, Textile, Leather Processing, Biotechnology & Pharmaceutical – Enzymes Immobilization, PEGlyation, Antibody Drug Conjugates (ADCs), Tissue Engineering and Regenerative Medicine, Production of Microparticles for Enteric Delivery, Others, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global transglutaminase market was valued at US$ 474.1 Mn in 2021, growing at an estimated CAGR of 7.5% over the forecast period. Transglutaminases are those enzymes that in nature mainly catalyse the formation of an isopeptide bond that is in between γ-carboxamide groups of glutamine residue side chains and the ε-amino groups of lysine residue side chains having adequate release of ammonia. In order to ensure process of cross-linking and intramolecular, Lysine and glutamine residues are needed to bind to a particular peptide or a protein. One of the major qualities of such bonds that are created through transglutaminase is that they showcase high resistance to proteolytic degradation. The intramolecular capability of transglutaminase is extensively used in numerous processes like making cheese, dairy products, processing the meat along with manufacturing edible films and bakery products. The global transglutaminase market is witnessing rapid growth due to numerous factors.
Similar to majority of markets, the global transglutaminase market incurred ample amount of losses owing to the pandemic caused by the COVID-19 virus. The demand for bakery, dairy products and meat fell.
Type Outlook
On the basis of type, the global transglutaminase market has been divided into tissue transglutaminase (tTG), and microbial transglutaminase (mTG). Compared to tissue transglutaminase, the microbial transglutaminase happens to be calcium independent, and possesses a single structural domain, along with having a varied reactivity to specific food proteins. This type of transglutaminase also weight lower on molecular level than the tissue one and accounts for maximum amount of revenue for this market. On the other hand, the tissue transglutaminase (tTG) happens to be calcium-dependant enzyme and weighs higher on the molecular level.
Global Transglutaminase Market Revenue & Forecast, (US$ Million), 2022 – 2030
Range Outlook
On the basis of range, the global transglutaminase market has been bifurcated into below 50 u/g, 51 u/g – 100 u/g and above 100 u/g. The 51 u/g – 100 u/g segment will make maximum money for this market.
Application Outlook
On the basis of applications, the global transglutaminase market has been categorised into food industry, textile, leather processing, biotechnology & pharmaceutical and others. The food industry segment is again divided into dairy, bakery, meat and poultry, fish and seafood, soyabean products and others. The dairy segment is further bifurcated into yoghurt, ice cream, cheese and others. While the bakery segment is further categorised into instant noodles, pasta and others, the biotechnology & pharmaceutical is divided again into enzymes immobilization, PEGylation, antibody drug conjugates (ADCs), tissue engineering and regenerative medicine, production of microparticles for enteric delivery, and others. The fish and seafood segment dominates in terms of market share.
Region Outlook
On the basis of region, the global transglutaminase market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America that comprises of leading nations like the United States and Canada has been dominating in terms of accumulating most of the money for this market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global transglutaminase market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global transglutaminase market are listed below:
- Ace Ingredients Co. Ltd
- AJINOMOTO FOODS
- Antozyme Biotech Pvt. Ltd
- Apex Biotechnol
- BDF NATURAL INGREDIENTS SL
- C & P Group GmbH
- Creative Enzymes
- Foodchem International Corporation
- Guangdong Kelong Biotechnology., Ltd
- Haihang Industry
- Jiangsu Yiming Biological Technology Co. Ltd
- Kinry Biotech Sdn Bhd
- Micro-Tech Food Ingredients, Inc.
- R&D Systems, Inc
- Ultreze Enzymes Pvt. Ltd
- Yesil Arma
- Other Market Participants
Global Transglutaminase Market
By Type
- Tissue Transglutaminase
- Microbial Transglutaminase (mTG)
By Range
- Below 50 u/g
- 51 u/g – 100 u/g
- Above 100 u/g
By Application
- Food Industry
- Dairy
- Yoghurt
- Ice Cream
- Cheese
- Others
- Bakery
- Instant Noodles
- Pasta
- Others
- Meat and Poultry
- Fish and Seafood
- Soyabean Products
- Others
- Dairy
- Textile
- Leather Processing
- Biotechnology
- Enzymes Immobilization
- PEGylation
- Antibody Drug Conjugates (ADCs)
- Tissue Engineering and Regenerative Medicine
- Production of Microparticles for Enteric Delivery
- Others
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 - 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Transglutaminase Market
6.
Market
Synopsis:Â Transglutaminase Market
7.
Transglutaminase
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Transglutaminase Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Transglutaminase Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Transglutaminase Market
8.
Global
Transglutaminase Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1. Global Transglutaminase Market Revenue (US$
Mn)
8.2. Global Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Type
8.2.1. Tissue Transglutaminase (tTG)
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2. Microbial Transglutaminase (mTG)
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Transglutaminase Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Range
9.2.1. Below 50 u/g
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2. 51 u/g – 100 u/g
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.2.3. Above 100 u/g
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Range
10. Global Transglutaminase Market Analysis and
Forecasts, 2022 - 2030
10.1. Overview
10.2. Global Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Application
10.2.1. Food Industry (Definition, Market Estimation
and Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast
(2022 - 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Dairy, Bakery, Meat and Poultry, Fish and Seafood, Soyabean
Products, Others)
10.2.1.1.
Dairy
10.2.1.1.1.
Yoghurt
10.2.1.1.2.
Ice
Cream
10.2.1.1.3.
Cheese
10.2.1.1.4.
Others
10.2.1.2.
Bakery
10.2.1.2.1.
Instant
Noodles
10.2.1.2.2.
Pasta
10.2.1.2.3.
Others
10.2.1.3.
Meat and
Poultry
10.2.1.4.
Fish and
Seafood
10.2.1.5.
Soyabean
Products
10.2.1.6.
Others
10.2.2. Textile
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Leather Processing
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Biotechnology (Definition, Market Estimation
and Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast
(2022 - 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Enzymes Immobilization, PEGylation, Antibody Drug Conjugates
(ADCs), Tissue Engineering and Regenerative Medicine, Production of
Microparticles for Enteric Delivery, Others)
10.2.4.1.
Enzymes
Immobilization
10.2.4.2.
PEGylation
10.2.4.3.
Antibody
Drug Conjugates (ADCs)
10.2.4.4.
Tissue
Engineering and Regenerative Medicine
10.2.4.5.
Production
of Microparticles for Enteric Delivery
10.2.4.6.
Others
10.2.5. Others
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.5.3.
Market
Forecast, 2022 - 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 - 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 - 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 - 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 - 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. North America Transglutaminase Market
Analysis and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. North America Transglutaminase Market Revenue
(US$ Mn)
11.2. North America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Type
11.2.1. Tissue Transglutaminase (tTG)
11.2.2. Microbial Transglutaminase (mTG)
11.3. North America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Range
11.3.1. Below 50 u/g
11.3.2. 51 u/g – 100 u/g
11.3.3. Above 100 u/g
11.4. North America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Application
11.4.1. Food Industry
11.4.1.1.
Dairy
11.4.1.1.1.
Yoghurt
11.4.1.1.2.
Ice
Cream
11.4.1.1.3.
Cheese
11.4.1.1.4.
Others
11.4.1.2.
Bakery
11.4.1.2.1.
Instant
Noodles
11.4.1.2.2.
Pasta
11.4.1.2.3.
Others
11.4.1.3.
Meat and
Poultry
11.4.1.4.
Fish and
Seafood
11.4.1.5.
Soyabean
Products
11.4.1.6.
Others
11.4.2. Textile
11.4.3. Leather Processing
11.4.4. Biotechnology
11.4.4.1.
Enzymes Immobilization
11.4.4.2.
PEGylation
11.4.4.3.
Antibody
Drug Conjugates (ADCs)
11.4.4.4.
Tissue
Engineering and Regenerative Medicine
11.4.4.5.
Production
of Microparticles for Enteric Delivery
11.4.4.6.
Others
11.4.5. Others
11.5. North America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1.
U.S Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Type
11.5.1.1.1.
Tissue
Transglutaminase (tTG)
11.5.1.1.2.
Microbial
Transglutaminase (mTG)
11.5.1.2.
U.S
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
11.5.1.2.1.
Below 50
u/g
11.5.1.2.2.
51 u/g –
100 u/g
11.5.1.2.3.
Above
100 u/g
11.5.1.3.
U.S Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.3.1.
Food
Industry
11.5.1.3.1.1. Dairy
11.5.1.3.1.1.1. Yoghurt
11.5.1.3.1.1.2. Ice Cream
11.5.1.3.1.1.3. Cheese
11.5.1.3.1.1.4. Others
11.5.1.3.1.2. Bakery
11.5.1.3.1.2.1. Instant Noodles
11.5.1.3.1.2.2. Pasta
11.5.1.3.1.2.3. Others
11.5.1.3.1.3. Meat and Poultry
11.5.1.3.1.4. Fish and Seafood
11.5.1.3.1.5. Soyabean Products
11.5.1.3.1.6. Others
11.5.1.3.2.
Textile
11.5.1.3.3.
Leather
Processing
11.5.1.3.4.
Biotechnology
11.5.1.3.4.1. Enzymes Immobilization
11.5.1.3.4.2. PEGylation
11.5.1.3.4.3. Antibody Drug Conjugates (ADCs)
11.5.1.3.4.4. Tissue Engineering and Regenerative Medicine
11.5.1.3.4.5. Production of Microparticles for Enteric
Delivery
11.5.1.3.4.6. Others
11.5.1.3.5.
Others
11.5.2. Canada
11.5.2.1.
Canada
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
11.5.2.1.1.
Tissue
Transglutaminase (tTG)
11.5.2.1.2.
Microbial
Transglutaminase (mTG)
11.5.2.2.
Canada
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
11.5.2.2.1.
Below 50
u/g
11.5.2.2.2.
51 u/g –
100 u/g
11.5.2.2.3.
Above
100 u/g
11.5.2.3.
Canada
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.3.1.
Food
Industry
11.5.2.3.1.1. Dairy
11.5.2.3.1.1.1. Yoghurt
11.5.2.3.1.1.2. Ice Cream
11.5.2.3.1.1.3. Cheese
11.5.2.3.1.1.4. Others
11.5.2.3.1.2. Bakery
11.5.2.3.1.2.1. Instant Noodles
11.5.2.3.1.2.2. Pasta
11.5.2.3.1.2.3. Others
11.5.2.3.1.3. Meat and Poultry
11.5.2.3.1.4. Fish and Seafood
11.5.2.3.1.5. Soyabean Products
11.5.2.3.1.6. Others
11.5.2.3.2.
Textile
11.5.2.3.3.
Leather
Processing
11.5.2.3.4.
Biotechnology
11.5.2.3.4.1. Enzymes Immobilization
11.5.2.3.4.2. PEGylation
11.5.2.3.4.3. Antibody Drug Conjugates (ADCs)
11.5.2.3.4.4. Tissue Engineering and Regenerative Medicine
11.5.2.3.4.5. Production of Microparticles for Enteric
Delivery
11.5.2.3.4.6. Others
11.5.2.3.5.
Others
11.5.3. Mexico
11.5.3.1.
Mexico
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
11.5.3.1.1.
Tissue
Transglutaminase (tTG)
11.5.3.1.2.
Microbial
Transglutaminase (mTG)
11.5.3.2.
Mexico
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
11.5.3.2.1.
Below 50
u/g
11.5.3.2.2.
51 u/g –
100 u/g
11.5.3.2.3.
Above
100 u/g
11.5.3.3.
Mexico
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.3.1.
Food
Industry
11.5.3.3.1.1. Dairy
11.5.3.3.1.1.1. Yoghurt
11.5.3.3.1.1.2. Ice Cream
11.5.3.3.1.1.3. Cheese
11.5.3.3.1.1.4. Others
11.5.3.3.1.2. Bakery
11.5.3.3.1.2.1. Instant Noodles
11.5.3.3.1.2.2. Pasta
11.5.3.3.1.2.3. Others
11.5.3.3.1.3. Meat and Poultry
11.5.3.3.1.4. Fish and Seafood
11.5.3.3.1.5. Soyabean Products
11.5.3.3.1.6. Others
11.5.3.3.2.
Textile
11.5.3.3.3.
Leather
Processing
11.5.3.3.4.
Biotechnology
11.5.3.3.4.1. Enzymes Immobilization
11.5.3.3.4.2. PEGylation
11.5.3.3.4.3. Antibody Drug Conjugates (ADCs)
11.5.3.3.4.4. Tissue Engineering and Regenerative Medicine
11.5.3.3.4.5. Production of Microparticles for Enteric
Delivery
11.5.3.3.4.6. Others
11.5.3.3.5.
Others
11.5.4. Rest of North America
11.5.4.1.
Rest of
North America Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
11.5.4.1.1.
Tissue
Transglutaminase (tTG)
11.5.4.1.2.
Microbial
Transglutaminase (mTG)
11.5.4.2.
Rest of
North America Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
11.5.4.2.1.
Below 50
u/g
11.5.4.2.2.
51 u/g –
100 u/g
11.5.4.2.3.
Above
100 u/g
11.5.4.3.
Rest of
North America Transglutaminase Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.3.1.
Food
Industry
11.5.4.3.1.1. Dairy
11.5.4.3.1.1.1. Yoghurt
11.5.4.3.1.1.2. Ice Cream
11.5.4.3.1.1.3. Cheese
11.5.4.3.1.1.4. Others
11.5.4.3.1.2. Bakery
11.5.4.3.1.2.1. Instant Noodles
11.5.4.3.1.2.2. Pasta
11.5.4.3.1.2.3. Others
11.5.4.3.1.3. Meat and Poultry
11.5.4.3.1.4. Fish and Seafood
11.5.4.3.1.5. Soyabean Products
11.5.4.3.1.6. Others
11.5.4.3.2.
Textile
11.5.4.3.3.
Leather
Processing
11.5.4.3.4.
Biotechnology
11.5.4.3.4.1. Enzymes Immobilization
11.5.4.3.4.2. PEGylation
11.5.4.3.4.3. Antibody Drug Conjugates (ADCs)
11.5.4.3.4.4. Tissue Engineering and Regenerative Medicine
11.5.4.3.4.5. Production of Microparticles for Enteric
Delivery
11.5.4.3.4.6. Others
11.5.4.3.5.
Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Type
11.6.3. By Range
11.6.4. By Application
12. Europe Transglutaminase Market Analysis and
Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Europe Transglutaminase Market Revenue (US$
Mn)
12.2. Europe Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Type
12.2.1. Tissue Transglutaminase (tTG)
12.2.2. Microbial Transglutaminase (mTG)
12.3. Europe Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Range
12.3.1. Below 50 u/g
12.3.2. 51 u/g – 100 u/g
12.3.3. Above 100 u/g
12.4. Europe Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Application
12.4.1. Food Industry
12.4.1.1.
Dairy
12.4.1.1.1.
Yoghurt
12.4.1.1.2.
Ice
Cream
12.4.1.1.3.
Cheese
12.4.1.1.4.
Others
12.4.1.2.
Bakery
12.4.1.2.1.
Instant
Noodles
12.4.1.2.2.
Pasta
12.4.1.2.3.
Others
12.4.1.3.
Meat and
Poultry
12.4.1.4.
Fish and
Seafood
12.4.1.5.
Soyabean
Products
12.4.1.6.
Others
12.4.2. Textile
12.4.3. Leather Processing
12.4.4. Biotechnology
12.4.4.1.
Enzymes
Immobilization
12.4.4.2.
PEGylation
12.4.4.3.
Antibody
Drug Conjugates (ADCs)
12.4.4.4.
Tissue
Engineering and Regenerative Medicine
12.4.4.5.
Production
of Microparticles for Enteric Delivery
12.4.4.6.
Others
12.4.5. Others
12.5. Europe Transglutaminase Market Revenue (US$
Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1.
France
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.1.1.1.
Tissue
Transglutaminase (tTG)
12.5.1.1.2.
Microbial
Transglutaminase (mTG)
12.5.1.2.
France
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.1.2.1.
Below 50
u/g
12.5.1.2.2.
51 u/g –
100 u/g
12.5.1.2.3.
Above
100 u/g
12.5.1.3.
France
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.3.1.
Food
Industry
12.5.1.3.1.1. Dairy
12.5.1.3.1.1.1. Yoghurt
12.5.1.3.1.1.2. Ice Cream
12.5.1.3.1.1.3. Cheese
12.5.1.3.1.1.4. Others
12.5.1.3.1.2. Bakery
12.5.1.3.1.2.1. Instant Noodles
12.5.1.3.1.2.2. Pasta
12.5.1.3.1.2.3. Others
12.5.1.3.1.3. Meat and Poultry
12.5.1.3.1.4. Fish and Seafood
12.5.1.3.1.5. Soyabean Products
12.5.1.3.1.6. Others
12.5.1.3.2.
Textile
12.5.1.3.3.
Leather
Processing
12.5.1.3.4.
Biotechnology
12.5.1.3.4.1. Enzymes Immobilization
12.5.1.3.4.2. PEGylation
12.5.1.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.1.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.1.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.1.3.4.6. Others
12.5.1.3.5.
Others
12.5.2. The UK
12.5.2.1.
The UK
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.2.1.1.
Tissue
Transglutaminase (tTG)
12.5.2.1.2.
Microbial
Transglutaminase (mTG)
12.5.2.2.
The UK
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.2.2.1.
Below 50
u/g
12.5.2.2.2.
51 u/g –
100 u/g
12.5.2.2.3.
Above
100 u/g
12.5.2.3.
The UK
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.3.1.
Food
Industry
12.5.2.3.1.1. Dairy
12.5.2.3.1.1.1. Yoghurt
12.5.2.3.1.1.2. Ice Cream
12.5.2.3.1.1.3. Cheese
12.5.2.3.1.1.4. Others
12.5.2.3.1.2. Bakery
12.5.2.3.1.2.1. Instant Noodles
12.5.2.3.1.2.2. Pasta
12.5.2.3.1.2.3. Others
12.5.2.3.1.3. Meat and Poultry
12.5.2.3.1.4. Fish and Seafood
12.5.2.3.1.5. Soyabean Products
12.5.2.3.1.6. Others
12.5.2.3.2.
Textile
12.5.2.3.3.
Leather
Processing
12.5.2.3.4.
Biotechnology
12.5.2.3.4.1. Enzymes Immobilization
12.5.2.3.4.2. PEGylation
12.5.2.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.2.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.2.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.2.3.4.6. Others
12.5.2.3.5.
Others
12.5.3. Spain
12.5.3.1.
Spain
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.3.1.1.
Tissue
Transglutaminase (tTG)
12.5.3.1.2.
Microbial
Transglutaminase (mTG)
12.5.3.2.
Spain
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.3.2.1.
Below 50
u/g
12.5.3.2.2.
51 u/g –
100 u/g
12.5.3.2.3.
Above
100 u/g
12.5.3.3.
Spain
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.3.1.
Food
Industry
12.5.3.3.1.1. Dairy
12.5.3.3.1.1.1. Yoghurt
12.5.3.3.1.1.2. Ice Cream
12.5.3.3.1.1.3. Cheese
12.5.3.3.1.1.4. Others
12.5.3.3.1.2. Bakery
12.5.3.3.1.2.1. Instant Noodles
12.5.3.3.1.2.2. Pasta
12.5.3.3.1.2.3. Others
12.5.3.3.1.3. Meat and Poultry
12.5.3.3.1.4. Fish and Seafood
12.5.3.3.1.5. Soyabean Products
12.5.3.3.1.6. Others
12.5.3.3.2.
Textile
12.5.3.3.3.
Leather
Processing
12.5.3.3.4.
Biotechnology
12.5.3.3.4.1. Enzymes Immobilization
12.5.3.3.4.2. PEGylation
12.5.3.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.3.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.3.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.3.3.4.6. Others
12.5.3.3.5.
Others
12.5.4. Germany
12.5.4.1.
Germany
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.4.1.1.
Tissue
Transglutaminase (tTG)
12.5.4.1.2.
Microbial
Transglutaminase (mTG)
12.5.4.2.
Germany
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.4.2.1.
Below 50
u/g
12.5.4.2.2.
51 u/g –
100 u/g
12.5.4.2.3.
Above
100 u/g
12.5.4.3.
Germany
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.3.1.
Food
Industry
12.5.4.3.1.1. Dairy
12.5.4.3.1.1.1. Yoghurt
12.5.4.3.1.1.2. Ice Cream
12.5.4.3.1.1.3. Cheese
12.5.4.3.1.1.4. Others
12.5.4.3.1.2. Bakery
12.5.4.3.1.2.1. Instant Noodles
12.5.4.3.1.2.2. Pasta
12.5.4.3.1.2.3. Others
12.5.4.3.1.3. Meat and Poultry
12.5.4.3.1.4. Fish and Seafood
12.5.4.3.1.5. Soyabean Products
12.5.4.3.1.6. Others
12.5.4.3.2.
Textile
12.5.4.3.3.
Leather
Processing
12.5.4.3.4.
Biotechnology
12.5.4.3.4.1. Enzymes Immobilization
12.5.4.3.4.2. PEGylation
12.5.4.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.4.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.4.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.4.3.4.6. Others
12.5.4.3.5.
Others
12.5.5. Italy
12.5.5.1.
Italy
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.5.1.1.
Tissue
Transglutaminase (tTG)
12.5.5.1.2.
Microbial
Transglutaminase (mTG)
12.5.5.2.
Italy
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.5.2.1.
Below 50
u/g
12.5.5.2.2.
51 u/g –
100 u/g
12.5.5.2.3.
Above
100 u/g
12.5.5.3.
Italy
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.3.1.
Food
Industry
12.5.5.3.1.1. Dairy
12.5.5.3.1.1.1. Yoghurt
12.5.5.3.1.1.2. Ice Cream
12.5.5.3.1.1.3. Cheese
12.5.5.3.1.1.4. Others
12.5.5.3.1.2. Bakery
12.5.5.3.1.2.1. Instant Noodles
12.5.5.3.1.2.2. Pasta
12.5.5.3.1.2.3. Others
12.5.5.3.1.3. Meat and Poultry
12.5.5.3.1.4. Fish and Seafood
12.5.5.3.1.5. Soyabean Products
12.5.5.3.1.6. Others
12.5.5.3.2.
Textile
12.5.5.3.3.
Leather Processing
12.5.5.3.4.
Biotechnology
12.5.5.3.4.1. Enzymes Immobilization
12.5.5.3.4.2. PEGylation
12.5.5.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.5.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.5.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.5.3.4.6. Others
12.5.5.3.5.
Others
12.5.6. Nordic Countries
12.5.6.1.
Nordic
Countries Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.6.1.1.
Tissue
Transglutaminase (tTG)
12.5.6.1.2.
Microbial
Transglutaminase (mTG)
12.5.6.2.
Nordic
Countries Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.6.2.1.
Below 50
u/g
12.5.6.2.2.
51 u/g –
100 u/g
12.5.6.2.3.
Above
100 u/g
12.5.6.3.
Nordic
Countries Transglutaminase Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.6.3.1.
Food
Industry
12.5.6.3.1.1. Dairy
12.5.6.3.1.1.1. Yoghurt
12.5.6.3.1.1.2. Ice Cream
12.5.6.3.1.1.3. Cheese
12.5.6.3.1.1.4. Others
12.5.6.3.1.2. Bakery
12.5.6.3.1.2.1. Instant Noodles
12.5.6.3.1.2.2. Pasta
12.5.6.3.1.2.3. Others
12.5.6.3.1.3. Meat and Poultry
12.5.6.3.1.4. Fish and Seafood
12.5.6.3.1.5. Soyabean Products
12.5.6.3.1.6. Others
12.5.6.3.2.
Textile
12.5.6.3.3.
Leather
Processing
12.5.6.3.4.
Biotechnology
12.5.6.3.4.1. Enzymes Immobilization
12.5.6.3.4.2. PEGylation
12.5.6.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.6.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.6.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.6.3.4.6. Others
12.5.6.3.5.
Others
12.5.6.4.
Nordic
Countries Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.
Denmark
12.5.6.4.2.
Finland
12.5.6.4.3.
Iceland
12.5.6.4.4.
Sweden
12.5.6.4.5.
Norway
12.5.7. Benelux Union
12.5.7.1.
Benelux
Union Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.7.1.1.
Tissue
Transglutaminase (tTG)
12.5.7.1.2.
Microbial
Transglutaminase (mTG)
12.5.7.2.
Benelux
Union Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.7.2.1.
Below 50
u/g
12.5.7.2.2.
51 u/g –
100 u/g
12.5.7.2.3.
Above
100 u/g
12.5.7.3.
Benelux
Union Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.3.1.
Food
Industry
12.5.7.3.1.1. Dairy
12.5.7.3.1.1.1. Yoghurt
12.5.7.3.1.1.2. Ice Cream
12.5.7.3.1.1.3. Cheese
12.5.7.3.1.1.4. Others
12.5.7.3.1.2. Bakery
12.5.7.3.1.2.1. Instant Noodles
12.5.7.3.1.2.2. Pasta
12.5.7.3.1.2.3. Others
12.5.7.3.1.3. Meat and Poultry
12.5.7.3.1.4. Fish and Seafood
12.5.7.3.1.5. Soyabean Products
12.5.7.3.1.6. Others
12.5.7.3.2.
Textile
12.5.7.3.3.
Leather
Processing
12.5.7.3.4.
Biotechnology
12.5.7.3.4.1. Enzymes Immobilization
12.5.7.3.4.2. PEGylation
12.5.7.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.7.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.7.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.7.3.4.6. Others
12.5.7.3.5.
Others
12.5.7.4.
Benelux
Union Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.
Belgium
12.5.7.4.2.
The
Netherlands
12.5.7.4.3.
Luxembourg
12.5.8. Rest of Europe
12.5.8.1.
Rest of
Europe Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
12.5.8.1.1.
Tissue
Transglutaminase (tTG)
12.5.8.1.2.
Microbial
Transglutaminase (mTG)
12.5.8.2.
Rest of
Europe Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
12.5.8.2.1.
Below 50
u/g
12.5.8.2.2.
51 u/g –
100 u/g
12.5.8.2.3.
Above
100 u/g
12.5.8.3.
Rest of
Europe Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.3.1.
Food
Industry
12.5.8.3.1.1. Dairy
12.5.8.3.1.1.1. Yoghurt
12.5.8.3.1.1.2. Ice Cream
12.5.8.3.1.1.3. Cheese
12.5.8.3.1.1.4. Others
12.5.8.3.1.2. Bakery
12.5.8.3.1.2.1. Instant Noodles
12.5.8.3.1.2.2. Pasta
12.5.8.3.1.2.3. Others
12.5.8.3.1.3. Meat and Poultry
12.5.8.3.1.4. Fish and Seafood
12.5.8.3.1.5. Soyabean Products
12.5.8.3.1.6. Others
12.5.8.3.2.
Textile
12.5.8.3.3.
Leather
Processing
12.5.8.3.4.
Biotechnology
12.5.8.3.4.1. Enzymes Immobilization
12.5.8.3.4.2. PEGylation
12.5.8.3.4.3. Antibody Drug Conjugates (ADCs)
12.5.8.3.4.4. Tissue Engineering and Regenerative Medicine
12.5.8.3.4.5. Production of Microparticles for Enteric
Delivery
12.5.8.3.4.6. Others
12.5.8.3.5.
Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Type
12.6.3. By Range
12.6.4. By Application
13. Asia Pacific Transglutaminase Market
Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Asia Pacific Transglutaminase Market Revenue
(US$ Mn)
13.2. Asia Pacific Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Type
13.2.1. Tissue Transglutaminase (tTG)
13.2.2. Microbial Transglutaminase (mTG)
13.3. Asia Pacific Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Range
13.3.1. Below 50 u/g
13.3.2. 51 u/g – 100 u/g
13.3.3. Above 100 u/g
13.4. Asia Pacific Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.1. Food Industry
13.4.1.1.
Dairy
13.4.1.1.1.
Yoghurt
13.4.1.1.2.
Ice
Cream
13.4.1.1.3.
Cheese
13.4.1.1.4.
Others
13.4.1.2.
Bakery
13.4.1.2.1.
Instant
Noodles
13.4.1.2.2.
Pasta
13.4.1.2.3.
Others
13.4.1.3.
Meat and
Poultry
13.4.1.4.
Fish and
Seafood
13.4.1.5.
Soyabean
Products
13.4.1.6.
Others
13.4.2. Textile
13.4.3. Leather Processing
13.4.4. Biotechnology
13.4.4.1.
Enzymes
Immobilization
13.4.4.2.
PEGylation
13.4.4.3.
Antibody
Drug Conjugates (ADCs)
13.4.4.4.
Tissue
Engineering and Regenerative Medicine
13.4.4.5.
Production
of Microparticles for Enteric Delivery
13.4.4.6.
Others
13.4.5. Others
13.5. Asia Pacific Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1.
China
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.1.1.1.
Tissue
Transglutaminase (tTG)
13.5.1.1.2.
Microbial
Transglutaminase (mTG)
13.5.1.2.
China
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.1.2.1.
Below 50
u/g
13.5.1.2.2.
51 u/g –
100 u/g
13.5.1.2.3.
Above
100 u/g
13.5.1.3.
China
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.3.1.
Food
Industry
13.5.1.3.1.1. Dairy
13.5.1.3.1.1.1. Yoghurt
13.5.1.3.1.1.2. Ice Cream
13.5.1.3.1.1.3. Cheese
13.5.1.3.1.1.4. Others
13.5.1.3.1.2. Bakery
13.5.1.3.1.2.1. Instant Noodles
13.5.1.3.1.2.2. Pasta
13.5.1.3.1.2.3. Others
13.5.1.3.1.3. Meat and Poultry
13.5.1.3.1.4. Fish and Seafood
13.5.1.3.1.5. Soyabean Products
13.5.1.3.1.6. Others
13.5.1.3.2.
Textile
13.5.1.3.3.
Leather
Processing
13.5.1.3.4.
Biotechnology
13.5.1.3.4.1. Enzymes Immobilization
13.5.1.3.4.2. PEGylation
13.5.1.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.1.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.1.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.1.3.4.6. Others
13.5.1.3.5.
Others
13.5.2. Japan
13.5.2.1.
Japan
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.2.1.1.
Tissue
Transglutaminase (tTG)
13.5.2.1.2.
Microbial
Transglutaminase (mTG)
13.5.2.2.
Japan
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.2.2.1.
Below 50
u/g
13.5.2.2.2.
51 u/g –
100 u/g
13.5.2.2.3.
Above
100 u/g
13.5.2.3.
Japan
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.3.1.
Food
Industry
13.5.2.3.1.1. Dairy
13.5.2.3.1.1.1. Yoghurt
13.5.2.3.1.1.2. Ice Cream
13.5.2.3.1.1.3. Cheese
13.5.2.3.1.1.4. Others
13.5.2.3.1.2. Bakery
13.5.2.3.1.2.1. Instant Noodles
13.5.2.3.1.2.2. Pasta
13.5.2.3.1.2.3. Others
13.5.2.3.1.3. Meat and Poultry
13.5.2.3.1.4. Fish and Seafood
13.5.2.3.1.5. Soyabean Products
13.5.2.3.1.6. Others
13.5.2.3.2.
Textile
13.5.2.3.3.
Leather
Processing
13.5.2.3.4.
Biotechnology
13.5.2.3.4.1. Enzymes Immobilization
13.5.2.3.4.2. PEGylation
13.5.2.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.2.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.2.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.2.3.4.6. Others
13.5.2.3.5.
Others
13.5.3. India
13.5.3.1.
India
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.3.1.1.
Tissue
Transglutaminase (tTG)
13.5.3.1.2.
Microbial
Transglutaminase (mTG)
13.5.3.2.
India
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.3.2.1.
Below 50
u/g
13.5.3.2.2.
51 u/g –
100 u/g
13.5.3.2.3.
Above
100 u/g
13.5.3.3.
India
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.3.1.
Food
Industry
13.5.3.3.1.1. Dairy
13.5.3.3.1.1.1. Yoghurt
13.5.3.3.1.1.2. Ice Cream
13.5.3.3.1.1.3. Cheese
13.5.3.3.1.1.4. Others
13.5.3.3.1.2. Bakery
13.5.3.3.1.2.1. Instant Noodles
13.5.3.3.1.2.2. Pasta
13.5.3.3.1.2.3. Others
13.5.3.3.1.3. Meat and Poultry
13.5.3.3.1.4. Fish and Seafood
13.5.3.3.1.5. Soyabean Products
13.5.3.3.1.6. Others
13.5.3.3.2.
Textile
13.5.3.3.3.
Leather
Processing
13.5.3.3.4.
Biotechnology
13.5.3.3.4.1. Enzymes Immobilization
13.5.3.3.4.2. PEGylation
13.5.3.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.3.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.3.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.3.3.4.6. Others
13.5.3.3.5.
Others
13.5.4. New Zealand
13.5.4.1.
New
Zealand Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.4.1.1.
Tissue
Transglutaminase (tTG)
13.5.4.1.2.
Microbial
Transglutaminase (mTG)
13.5.4.2.
New
Zealand Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.4.2.1.
Below 50
u/g
13.5.4.2.2.
51 u/g –
100 u/g
13.5.4.2.3.
Above
100 u/g
13.5.4.3.
New
Zealand Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.3.1.
Food
Industry
13.5.4.3.1.1. Dairy
13.5.4.3.1.1.1. Yoghurt
13.5.4.3.1.1.2. Ice Cream
13.5.4.3.1.1.3. Cheese
13.5.4.3.1.1.4. Others
13.5.4.3.1.2. Bakery
13.5.4.3.1.2.1. Instant Noodles
13.5.4.3.1.2.2. Pasta
13.5.4.3.1.2.3. Others
13.5.4.3.1.3. Meat and Poultry
13.5.4.3.1.4. Fish and Seafood
13.5.4.3.1.5. Soyabean Products
13.5.4.3.1.6. Others
13.5.4.3.2.
Textile
13.5.4.3.3.
Leather
Processing
13.5.4.3.4.
Biotechnology
13.5.4.3.4.1. Enzymes Immobilization
13.5.4.3.4.2. PEGylation
13.5.4.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.4.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.4.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.4.3.4.6. Others
13.5.4.3.5.
Others
13.5.5. Australia
13.5.5.1.
Australia
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.5.1.1.
Tissue
Transglutaminase (tTG)
13.5.5.1.2.
Microbial
Transglutaminase (mTG)
13.5.5.2.
Australia
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.5.2.1.
Below 50
u/g
13.5.5.2.2.
51 u/g –
100 u/g
13.5.5.2.3.
Above
100 u/g
13.5.5.3.
Australia
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.3.1.
Food
Industry
13.5.5.3.1.1. Dairy
13.5.5.3.1.1.1. Yoghurt
13.5.5.3.1.1.2. Ice Cream
13.5.5.3.1.1.3. Cheese
13.5.5.3.1.1.4. Others
13.5.5.3.1.2. Bakery
13.5.5.3.1.2.1. Instant Noodles
13.5.5.3.1.2.2. Pasta
13.5.5.3.1.2.3. Others
13.5.5.3.1.3. Meat and Poultry
13.5.5.3.1.4. Fish and Seafood
13.5.5.3.1.5. Soyabean Products
13.5.5.3.1.6. Others
13.5.5.3.2.
Textile
13.5.5.3.3.
Leather
Processing
13.5.5.3.4.
Biotechnology
13.5.5.3.4.1. Enzymes Immobilization
13.5.5.3.4.2. PEGylation
13.5.5.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.5.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.5.3.4.5. Production of Microparticles for Enteric Delivery
13.5.5.3.4.6. Others
13.5.5.3.5.
Others
13.5.6. South Korea
13.5.6.1.
South
Korea Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.6.1.1.
Tissue
Transglutaminase (tTG)
13.5.6.1.2.
Microbial
Transglutaminase (mTG)
13.5.6.2.
South
Korea Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.6.2.1.
Below 50
u/g
13.5.6.2.2.
51 u/g –
100 u/g
13.5.6.2.3.
Above
100 u/g
13.5.6.3.
South
Korea Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.3.1.
Food
Industry
13.5.6.3.1.1. Dairy
13.5.6.3.1.1.1. Yoghurt
13.5.6.3.1.1.2. Ice Cream
13.5.6.3.1.1.3. Cheese
13.5.6.3.1.1.4. Others
13.5.6.3.1.2. Bakery
13.5.6.3.1.2.1. Instant Noodles
13.5.6.3.1.2.2. Pasta
13.5.6.3.1.2.3. Others
13.5.6.3.1.3. Meat and Poultry
13.5.6.3.1.4. Fish and Seafood
13.5.6.3.1.5. Soyabean Products
13.5.6.3.1.6. Others
13.5.6.3.2.
Textile
13.5.6.3.3.
Leather
Processing
13.5.6.3.4.
Biotechnology
13.5.6.3.4.1. Enzymes Immobilization
13.5.6.3.4.2. PEGylation
13.5.6.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.6.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.6.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.6.3.4.6. Others
13.5.6.3.5.
Others
13.5.7. Southeast Asia
13.5.7.1.
Southeast
Asia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.7.1.1.
Tissue
Transglutaminase (tTG)
13.5.7.1.2.
Microbial
Transglutaminase (mTG)
13.5.7.2.
Southeast
Asia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.7.2.1.
Below 50
u/g
13.5.7.2.2.
51 u/g –
100 u/g
13.5.7.2.3.
Above
100 u/g
13.5.7.3.
Southeast
Asia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.3.1.
Food
Industry
13.5.7.3.1.1. Dairy
13.5.7.3.1.1.1. Yoghurt
13.5.7.3.1.1.2. Ice Cream
13.5.7.3.1.1.3. Cheese
13.5.7.3.1.1.4. Others
13.5.7.3.1.2. Bakery
13.5.7.3.1.2.1. Instant Noodles
13.5.7.3.1.2.2. Pasta
13.5.7.3.1.2.3. Others
13.5.7.3.1.3. Meat and Poultry
13.5.7.3.1.4. Fish and Seafood
13.5.7.3.1.5. Soyabean Products
13.5.7.3.1.6. Others
13.5.7.3.2.
Textile
13.5.7.3.3.
Leather
Processing
13.5.7.3.4.
Biotechnology
13.5.7.3.4.1. Enzymes Immobilization
13.5.7.3.4.2. PEGylation
13.5.7.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.7.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.7.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.7.3.4.6. Others
13.5.7.3.5.
Others
13.5.7.4.
Southeast
Asia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.
Indonesia
13.5.7.4.2.
Thailand
13.5.7.4.3.
Malaysia
13.5.7.4.4.
Singapore
13.5.7.4.5.
Rest of
Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1.
Rest of
Asia Pacific Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
13.5.8.1.1.
Tissue
Transglutaminase (tTG)
13.5.8.1.2.
Microbial
Transglutaminase (mTG)
13.5.8.2.
Rest of
Asia Pacific Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
13.5.8.2.1.
Below 50
u/g
13.5.8.2.2.
51 u/g –
100 u/g
13.5.8.2.3.
Above
100 u/g
13.5.8.3.
Rest of
Asia Pacific Transglutaminase Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.8.3.1.
Food
Industry
13.5.8.3.1.1. Dairy
13.5.8.3.1.1.1. Yoghurt
13.5.8.3.1.1.2. Ice Cream
13.5.8.3.1.1.3. Cheese
13.5.8.3.1.1.4. Others
13.5.8.3.1.2. Bakery
13.5.8.3.1.2.1. Instant Noodles
13.5.8.3.1.2.2. Pasta
13.5.8.3.1.2.3. Others
13.5.8.3.1.3. Meat and Poultry
13.5.8.3.1.4. Fish and Seafood
13.5.8.3.1.5. Soyabean Products
13.5.8.3.1.6. Others
13.5.8.3.2.
Textile
13.5.8.3.3.
Leather
Processing
13.5.8.3.4.
Biotechnology
13.5.8.3.4.1. Enzymes Immobilization
13.5.8.3.4.2. PEGylation
13.5.8.3.4.3. Antibody Drug Conjugates (ADCs)
13.5.8.3.4.4. Tissue Engineering and Regenerative Medicine
13.5.8.3.4.5. Production of Microparticles for Enteric
Delivery
13.5.8.3.4.6. Others
13.5.8.3.5.
Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Type
13.6.3. By Range
13.6.4. By Application
14. Middle East and Africa Transglutaminase
Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Middle East and Africa Transglutaminase
Market Revenue (US$ Mn)
14.2. Middle East and Africa Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Tissue Transglutaminase (tTG)
14.2.2. Microbial Transglutaminase (mTG)
14.3. Middle East and Africa Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Range
14.3.1. Below 50 u/g
14.3.2. 51 u/g – 100 u/g
14.3.3. Above 100 u/g
14.4. Middle East and Africa Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Food Industry
14.4.1.1.
Dairy
14.4.1.1.1.
Yoghurt
14.4.1.1.2.
Ice
Cream
14.4.1.1.3.
Cheese
14.4.1.1.4.
Others
14.4.1.2.
Bakery
14.4.1.2.1.
Instant
Noodles
14.4.1.2.2.
Pasta
14.4.1.2.3.
Others
14.4.1.3.
Meat and
Poultry
14.4.1.4.
Fish and
Seafood
14.4.1.5.
Soyabean
Products
14.4.1.6.
Others
14.4.2. Textile
14.4.3. Leather Processing
14.4.4. Biotechnology
14.4.4.1.
Enzymes
Immobilization
14.4.4.2.
PEGylation
14.4.4.3.
Antibody
Drug Conjugates (ADCs)
14.4.4.4.
Tissue
Engineering and Regenerative Medicine
14.4.4.5.
Production
of Microparticles for Enteric Delivery
14.4.4.6.
Others
14.4.5. Others
14.5. Middle East and Africa Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1.
Saudi
Arabia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
14.5.1.1.1.
Tissue
Transglutaminase (tTG)
14.5.1.1.2.
Microbial
Transglutaminase (mTG)
14.5.1.2.
Saudi
Arabia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
14.5.1.2.1.
Below 50
u/g
14.5.1.2.2.
51 u/g –
100 u/g
14.5.1.2.3.
Above
100 u/g
14.5.1.3.
Saudi
Arabia Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.3.1.
Food
Industry
14.5.1.3.1.1. Dairy
14.5.1.3.1.1.1. Yoghurt
14.5.1.3.1.1.2. Ice Cream
14.5.1.3.1.1.3. Cheese
14.5.1.3.1.1.4. Others
14.5.1.3.1.2. Bakery
14.5.1.3.1.2.1. Instant Noodles
14.5.1.3.1.2.2. Pasta
14.5.1.3.1.2.3. Others
14.5.1.3.1.3. Meat and Poultry
14.5.1.3.1.4. Fish and Seafood
14.5.1.3.1.5. Soyabean Products
14.5.1.3.1.6. Others
14.5.1.3.2.
Textile
14.5.1.3.3.
Leather
Processing
14.5.1.3.4.
Biotechnology
14.5.1.3.4.1. Enzymes Immobilization
14.5.1.3.4.2. PEGylation
14.5.1.3.4.3. Antibody Drug Conjugates (ADCs)
14.5.1.3.4.4. Tissue Engineering and Regenerative Medicine
14.5.1.3.4.5. Production of Microparticles for Enteric
Delivery
14.5.1.3.4.6. Others
14.5.1.3.5.
Others
14.5.2. UAE
14.5.2.1.
UAE
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
14.5.2.1.1.
Tissue
Transglutaminase (tTG)
14.5.2.1.2.
Microbial
Transglutaminase (mTG)
14.5.2.2.
UAE
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
14.5.2.2.1.
Below 50
u/g
14.5.2.2.2.
51 u/g –
100 u/g
14.5.2.2.3.
Above
100 u/g
14.5.2.3.
UAE
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.3.1.
Food
Industry
14.5.2.3.1.1. Dairy
14.5.2.3.1.1.1. Yoghurt
14.5.2.3.1.1.2. Ice Cream
14.5.2.3.1.1.3. Cheese
14.5.2.3.1.1.4. Others
14.5.2.3.1.2. Bakery
14.5.2.3.1.2.1. Instant Noodles
14.5.2.3.1.2.2. Pasta
14.5.2.3.1.2.3. Others
14.5.2.3.1.3. Meat and Poultry
14.5.2.3.1.4. Fish and Seafood
14.5.2.3.1.5. Soyabean Products
14.5.2.3.1.6. Others
14.5.2.3.2.
Textile
14.5.2.3.3.
Leather
Processing
14.5.2.3.4.
Biotechnology
14.5.2.3.4.1. Enzymes Immobilization
14.5.2.3.4.2. PEGylation
14.5.2.3.4.3. Antibody Drug Conjugates (ADCs)
14.5.2.3.4.4. Tissue Engineering and Regenerative Medicine
14.5.2.3.4.5. Production of Microparticles for Enteric
Delivery
14.5.2.3.4.6. Others
14.5.2.3.5.
Others
14.5.3. Egypt
14.5.3.1.
Egypt
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
14.5.3.1.1.
Tissue
Transglutaminase (tTG)
14.5.3.1.2.
Microbial
Transglutaminase (mTG)
14.5.3.2.
Egypt
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
14.5.3.2.1.
Below 50
u/g
14.5.3.2.2.
51 u/g –
100 u/g
14.5.3.2.3.
Above
100 u/g
14.5.3.3.
Egypt Transglutaminase
Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.3.1.
Food
Industry
14.5.3.3.1.1. Dairy
14.5.3.3.1.1.1. Yoghurt
14.5.3.3.1.1.2. Ice Cream
14.5.3.3.1.1.3. Cheese
14.5.3.3.1.1.4. Others
14.5.3.3.1.2. Bakery
14.5.3.3.1.2.1. Instant Noodles
14.5.3.3.1.2.2. Pasta
14.5.3.3.1.2.3. Others
14.5.3.3.1.3. Meat and Poultry
14.5.3.3.1.4. Fish and Seafood
14.5.3.3.1.5. Soyabean Products
14.5.3.3.1.6. Others
14.5.3.3.2.
Textile
14.5.3.3.3.
Leather
Processing
14.5.3.3.4.
Biotechnology
14.5.3.3.4.1. Enzymes Immobilization
14.5.3.3.4.2. PEGylation
14.5.3.3.4.3. Antibody Drug Conjugates (ADCs)
14.5.3.3.4.4. Tissue Engineering and Regenerative Medicine
14.5.3.3.4.5. Production of Microparticles for Enteric
Delivery
14.5.3.3.4.6. Others
14.5.3.3.5.
Others
14.5.4. Kuwait
14.5.4.1.
Kuwait
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
14.5.4.1.1.
Tissue
Transglutaminase (tTG)
14.5.4.1.2.
Microbial
Transglutaminase (mTG)
14.5.4.2.
Kuwait
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
14.5.4.2.1.
Below 50
u/g
14.5.4.2.2.
51 u/g –
100 u/g
14.5.4.2.3.
Above
100 u/g
14.5.4.3.
Kuwait
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.3.1.
Food
Industry
14.5.4.3.1.1. Dairy
14.5.4.3.1.1.1. Yoghurt
14.5.4.3.1.1.2. Ice Cream
14.5.4.3.1.1.3. Cheese
14.5.4.3.1.1.4. Others
14.5.4.3.1.2. Bakery
14.5.4.3.1.2.1. Instant Noodles
14.5.4.3.1.2.2. Pasta
14.5.4.3.1.2.3. Others
14.5.4.3.1.3. Meat and Poultry
14.5.4.3.1.4. Fish and Seafood
14.5.4.3.1.5. Soyabean Products
14.5.4.3.1.6. Others
14.5.4.3.2.
Textile
14.5.4.3.3.
Leather
Processing
14.5.4.3.4.
Biotechnology
14.5.4.3.4.1. Enzymes Immobilization
14.5.4.3.4.2. PEGylation
14.5.4.3.4.3. Antibody Drug Conjugates (ADCs)
14.5.4.3.4.4. Tissue Engineering and Regenerative Medicine
14.5.4.3.4.5. Production of Microparticles for Enteric
Delivery
14.5.4.3.4.6. Others
14.5.4.3.5.
Others
14.5.5. South Africa
14.5.5.1.
South
Africa Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
14.5.5.1.1.
Tissue
Transglutaminase (tTG)
14.5.5.1.2.
Microbial
Transglutaminase (mTG)
14.5.5.2.
South
Africa Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
14.5.5.2.1.
Below 50
u/g
14.5.5.2.2.
51 u/g –
100 u/g
14.5.5.2.3.
Above
100 u/g
14.5.5.3.
South
Africa Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.3.1.
Food
Industry
14.5.5.3.1.1. Dairy
14.5.5.3.1.1.1. Yoghurt
14.5.5.3.1.1.2. Ice Cream
14.5.5.3.1.1.3. Cheese
14.5.5.3.1.1.4. Others
14.5.5.3.1.2. Bakery
14.5.5.3.1.2.1. Instant Noodles
14.5.5.3.1.2.2. Pasta
14.5.5.3.1.2.3. Others
14.5.5.3.1.3. Meat and Poultry
14.5.5.3.1.4. Fish and Seafood
14.5.5.3.1.5. Soyabean Products
14.5.5.3.1.6. Others
14.5.5.3.2.
Textile
14.5.5.3.3.
Leather
Processing
14.5.5.3.4.
Biotechnology
14.5.5.3.4.1. Enzymes Immobilization
14.5.5.3.4.2. PEGylation
14.5.5.3.4.3. Antibody Drug Conjugates (ADCs)
14.5.5.3.4.4. Tissue Engineering and Regenerative Medicine
14.5.5.3.4.5. Production of Microparticles for Enteric
Delivery
14.5.5.3.4.6. Others
14.5.5.3.5.
Others
14.5.6. Rest of Middle East & Africa
14.5.6.1.
Rest of
Middle East & Africa Transglutaminase Market Revenue (US$ Mn) and
Forecasts, By Type
14.5.6.1.1.
Tissue
Transglutaminase (tTG)
14.5.6.1.2.
Microbial
Transglutaminase (mTG)
14.5.6.2.
Rest of
Middle East & Africa Transglutaminase Market Revenue (US$ Mn) and
Forecasts, By Range
14.5.6.2.1.
Below 50
u/g
14.5.6.2.2.
51 u/g –
100 u/g
14.5.6.2.3.
Above
100 u/g
14.5.6.3.
Rest of
Middle East & Africa Transglutaminase Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.6.3.1.
Food
Industry
14.5.6.3.1.1. Dairy
14.5.6.3.1.1.1. Yoghurt
14.5.6.3.1.1.2. Ice Cream
14.5.6.3.1.1.3. Cheese
14.5.6.3.1.1.4. Others
14.5.6.3.1.2. Bakery
14.5.6.3.1.2.1. Instant Noodles
14.5.6.3.1.2.2. Pasta
14.5.6.3.1.2.3. Others
14.5.6.3.1.3. Meat and Poultry
14.5.6.3.1.4. Fish and Seafood
14.5.6.3.1.5. Soyabean Products
14.5.6.3.1.6. Others
14.5.6.3.2.
Textile
14.5.6.3.3.
Leather
Processing
14.5.6.3.4.
Biotechnology
14.5.6.3.4.1. Enzymes Immobilization
14.5.6.3.4.2. PEGylation
14.5.6.3.4.3. Antibody Drug Conjugates (ADCs)
14.5.6.3.4.4. Tissue Engineering and Regenerative Medicine
14.5.6.3.4.5. Production of Microparticles for Enteric
Delivery
14.5.6.3.4.6. Others
14.5.6.3.5.
Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Type
14.6.3. By Range
14.6.4. By Application
15. Latin America Transglutaminase Market
Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Latin America Transglutaminase Market Revenue
(US$ Mn)
15.2. Latin America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Type
15.2.1. Tissue Transglutaminase (tTG)
15.2.2. Microbial Transglutaminase (mTG)
15.3. Latin America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Range
15.3.1. Below 50 u/g
15.3.2. 51 u/g – 100 u/g
15.3.3. Above 100 u/g
15.4. Latin America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Application
15.4.1. Food Industry
15.4.1.1.
Dairy
15.4.1.1.1.
Yoghurt
15.4.1.1.2.
Ice
Cream
15.4.1.1.3.
Cheese
15.4.1.1.4.
Others
15.4.1.2.
Bakery
15.4.1.2.1.
Instant
Noodles
15.4.1.2.2.
Pasta
15.4.1.2.3.
Others
15.4.1.3.
Meat and
Poultry
15.4.1.4.
Fish and
Seafood
15.4.1.5.
Soyabean
Products
15.4.1.6.
Others
15.4.2. Textile
15.4.3. Leather Processing
15.4.4. Biotechnology
15.4.4.1.
Enzymes
Immobilization
15.4.4.2.
PEGylation
15.4.4.3.
Antibody
Drug Conjugates (ADCs)
15.4.4.4.
Tissue
Engineering and Regenerative Medicine
15.4.4.5.
Production
of Microparticles for Enteric Delivery
15.4.4.6.
Others
15.4.5. Others
15.5. Latin America Transglutaminase Market Revenue
(US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1.
Brazil
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
15.5.1.1.1.
Tissue
Transglutaminase (tTG)
15.5.1.1.2.
Microbial
Transglutaminase (mTG)
15.5.1.2.
Brazil
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
15.5.1.2.1.
Below 50
u/g
15.5.1.2.2.
51 u/g –
100 u/g
15.5.1.2.3.
Above
100 u/g
15.5.1.3.
Brazil
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.3.1.
Food
Industry
15.5.1.3.1.1. Dairy
15.5.1.3.1.1.1. Yoghurt
15.5.1.3.1.1.2. Ice Cream
15.5.1.3.1.1.3. Cheese
15.5.1.3.1.1.4. Others
15.5.1.3.1.2. Bakery
15.5.1.3.1.2.1. Instant Noodles
15.5.1.3.1.2.2. Pasta
15.5.1.3.1.2.3. Others
15.5.1.3.1.3. Meat and Poultry
15.5.1.3.1.4. Fish and Seafood
15.5.1.3.1.5. Soyabean Products
15.5.1.3.1.6. Others
15.5.1.3.2.
Textile
15.5.1.3.3.
Leather
Processing
15.5.1.3.4.
Biotechnology
15.5.1.3.4.1. Enzymes Immobilization
15.5.1.3.4.2. PEGylation
15.5.1.3.4.3. Antibody Drug Conjugates (ADCs)
15.5.1.3.4.4. Tissue Engineering and Regenerative Medicine
15.5.1.3.4.5. Production of Microparticles for Enteric Delivery
15.5.1.3.4.6. Others
15.5.1.3.5.
Others
15.5.2. Argentina
15.5.2.1.
Argentina
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
15.5.2.1.1.
Tissue
Transglutaminase (tTG)
15.5.2.1.2.
Microbial
Transglutaminase (mTG)
15.5.2.2.
Argentina
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
15.5.2.2.1.
Below 50
u/g
15.5.2.2.2.
51 u/g –
100 u/g
15.5.2.2.3.
Above
100 u/g
15.5.2.3.
Argentina
Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.3.1.
Food
Industry
15.5.2.3.1.1. Dairy
15.5.2.3.1.1.1. Yoghurt
15.5.2.3.1.1.2. Ice Cream
15.5.2.3.1.1.3. Cheese
15.5.2.3.1.1.4. Others
15.5.2.3.1.2. Bakery
15.5.2.3.1.2.1. Instant Noodles
15.5.2.3.1.2.2. Pasta
15.5.2.3.1.2.3. Others
15.5.2.3.1.3. Meat and Poultry
15.5.2.3.1.4. Fish and Seafood
15.5.2.3.1.5. Soyabean Products
15.5.2.3.1.6. Others
15.5.2.3.2.
Textile
15.5.2.3.3.
Leather
Processing
15.5.2.3.4.
Biotechnology
15.5.2.3.4.1. Enzymes Immobilization
15.5.2.3.4.2. PEGylation
15.5.2.3.4.3. Antibody Drug Conjugates (ADCs)
15.5.2.3.4.4. Tissue Engineering and Regenerative Medicine
15.5.2.3.4.5. Production of Microparticles for Enteric
Delivery
15.5.2.3.4.6. Others
15.5.2.3.5.
Others
15.5.3. Rest of Latin America
15.5.3.1.
Rest of Latin
America Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Type
15.5.3.1.1.
Tissue
Transglutaminase (tTG)
15.5.3.1.2.
Microbial
Transglutaminase (mTG)
15.5.3.2.
Rest of
Latin America Transglutaminase Market Revenue (US$ Mn) and Forecasts, By Range
15.5.3.2.1.
Below 50
u/g
15.5.3.2.2.
51 u/g –
100 u/g
15.5.3.2.3.
Above
100 u/g
15.5.3.3.
Rest of
Latin America Transglutaminase Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.3.1.
Food
Industry
15.5.3.3.1.1. Dairy
15.5.3.3.1.1.1. Yoghurt
15.5.3.3.1.1.2. Ice Cream
15.5.3.3.1.1.3. Cheese
15.5.3.3.1.1.4. Others
15.5.3.3.1.2. Bakery
15.5.3.3.1.2.1. Instant Noodles
15.5.3.3.1.2.2. Pasta
15.5.3.3.1.2.3. Others
15.5.3.3.1.3. Meat and Poultry
15.5.3.3.1.4. Fish and Seafood
15.5.3.3.1.5. Soyabean Products
15.5.3.3.1.6. Others
15.5.3.3.2.
Textile
15.5.3.3.3.
Leather
Processing
15.5.3.3.4.
Biotechnology
15.5.3.3.4.1. Enzymes Immobilization
15.5.3.3.4.2. PEGylation
15.5.3.3.4.3. Antibody Drug Conjugates (ADCs)
15.5.3.3.4.4. Tissue Engineering and Regenerative Medicine
15.5.3.3.4.5. Production of Microparticles for Enteric
Delivery
15.5.3.3.4.6. Others
15.5.3.3.5.
Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Type
15.6.3. By Range
15.6.4. By Application
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2021
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Ace Ingredients Co. Ltd.
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. AJINOMOTO FOODS
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Antozyme Biotech Pvt. Ltd
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. Apex Biotechnol
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. BDF NATURAL INGREDIENTS SL
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. C & P Group GmbH
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Creative Enzymes
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. Foodchem International Corporation
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Guangdong Kelong Biotechnology., Ltd
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business Strategies
17.10. Haihang Industry
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. Jiangsu Yiming Biological Technology Co. Ltd
17.11.1. Company Details
17.11.2. Company Overview
17.11.3. Product Offerings
17.11.4. Key Developments
17.11.5. Financial Analysis
17.11.6. SWOT Analysis
17.11.7. Business Strategies
17.12. Kinry Biotech Sdn Bhd
17.12.1. Company Details
17.12.2. Company Overview
17.12.3. Product Offerings
17.12.4. Key Developments
17.12.5. Financial Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Micro-Tech Food Ingredients, Inc.
17.13.1. Company Details
17.13.2. Company Overview
17.13.3. Product Offerings
17.13.4. Key Developments
17.13.5. Financial Analysis
17.13.6. SWOT Analysis
17.13.7. Business Strategies
17.14. R&D Systems, Inc
17.14.1. Company Details
17.14.2. Company Overview
17.14.3. Product Offerings
17.14.4. Key Developments
17.14.5. Financial Analysis
17.14.6. SWOT Analysis
17.14.7. Business Strategies
17.15. Ultreze Enzymes Pvt. Ltd
17.15.1. Company Details
17.15.2. Company Overview
17.15.3. Product Offerings
17.15.4. Key Developments
17.15.5. Financial Analysis
17.15.6. SWOT Analysis
17.15.7. Business Strategies
17.16. Yesil Arma
17.16.1. Company Details
17.16.2. Company Overview
17.16.3. Product Offerings
17.16.4. Key Developments
17.16.5. Financial Analysis
17.16.6. SWOT Analysis
17.16.7. Business Strategies
17.17. Other Market Participants
18. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.